Both in Biotechnology
Inhibrx Biosciences vs Vor Biopharma
Over the past year INBX returned +5.8% and VOR returned −2.1%; their daily moves had a correlation of 0.14.
INBX +5.8% VOR −2.1%Growth of $1, one year, split-adjusted
| Metric | INBX | VOR |
|---|---|---|
| Price | $86.76 | $20.12 |
| Market cap | $1.28B | $1.24B |
| Today | +7.01% | +1.31% |
| 1 month | −7.1% | +9.9% |
| 6 months | −38.8% | +26.5% |
| Year to date | +9.8% | +53.8% |
| 1 year | +6.5% | −10.2% |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | 0.9× |
| Price / sales | — | — |
| Net cash | -$42.9M | $481.6M |
| Dividend yield | — | — |
| Volatility (60d) | 88.8% | 59.2% |
| Short % of float | 35.5% | 17.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).